AI in Drug Development Podcast – Anchor FM
CytoReason’s Machine-Learning Model Offers New Insights Into Immune-Related Diseases
CytoReason uses AI to personalize drugs, opening the door to cancer treatments
Hey Doc, how’s my immune system doing? Shen-Orr
